David Efraim Rosen's Net Worth
$0
Estimate Recalculated Nov 7, 2024 12:03PM EST
Who is David Efraim Rosen?
David Efraim Rosen does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vincerx Pharma, Inc., Radius Health, Inc., TherapeuticsMD, Inc., HERON THERAPEUTICS, INC. /DE/, Mereo BioPharma Group plc, and Talen Energy Corp.
SEC CIK
David Efraim Rosen's CIK is 0001898677
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vincerx Pharma, Inc. (VINC) Snapshot price: $0.7122
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Radius Health, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.11% | 1.68M |
$10.07 | $16,907,066.78 | 8.64M |
Aug 11
| |||
Form 4
| +0.06% | 4.01K |
$10.07 | $40,400.84 | 6.96M |
Aug 10
| |||
Form 4
| +2.15% | 146.69K |
$7.07 | $1,037,752.37 | 6.96M |
Dec 16
| |||
Form 4
| +3.59% | 462.24K |
$6.93 | $3,191,375.65 | 13.35M |
Dec 13 - Dec 15
| |||
Form 4
| +15.82% | 1.59M |
$7.65 | $12,015,791.72 | 11.67M |
Dec 8 - Dec 10
| |||
| No matching records found | |||||||||
TherapeuticsMD, Inc. (TXMD) Snapshot price: $1.9
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +42.38% | 877.19K |
$2.28 | $1,999,997.76 | 2.95M |
Nov 15
| |||
Form 4
| +17.79% | 312.52K |
$3.68 | $1,149,998.24 | 2.07M |
Jun 28
| |||
Form 4/A
| -100.00% | -29.00K |
$1,333.00 | -$38,657,000.00 |
0
|
Dec 30
| |||
Form 4
| -100.00% | -29.00K |
$1,333.00 | -$38,657,000.00 |
0
|
Dec 30
| |||
Form 4
| +0.85% | 14.82K |
$6.09 | $90,284.25 | 1.76M |
Dec 9
| |||
Form 4
| +0.59% | 20.41K |
$5.75 | $115,638.86 | 3.48M |
Dec 7 - Dec 8
| |||
Form 4
| +31.82% | 7K |
$1,000.00 | $7,000,000.00 | 29K |
Oct 28
| |||
Form 4
| +46.67% | 7K |
$1,000.00 | $7,000,000.00 | 22K |
Sep 30
| |||
Form 4
| +50.13% | 580K |
$413.47 | $14,999,950.00 | 1.74M |
Jul 29
| |||
Form 4
| +3.73% | 82.58K |
$5.80 | $467,458.16 | 2.3M |
Jul 15 - Jul 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HERON THERAPEUTICS, INC. /DE/ (HRTX) Snapshot price: $1.81
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mereo BioPharma Group plc (MREO) Snapshot price: $4.3
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||